Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed Indications

Clinical trial NCT06121271 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06121271
Sponsor: University College, London
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bronchial and Thymic Neuroendocrine Tumour Paraganglioma/ Phaeochromocytoma Medullary Thyroid Carcinoma Those Requiring Repeat Peptide Receptor Radionuclide Therapy

Start date: 2023-12-18
Primary completion: 2027-11-06
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.